NO158578C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater.

Info

Publication number
NO158578C
NO158578C NO812355A NO812355A NO158578C NO 158578 C NO158578 C NO 158578C NO 812355 A NO812355 A NO 812355A NO 812355 A NO812355 A NO 812355A NO 158578 C NO158578 C NO 158578C
Authority
NO
Norway
Prior art keywords
group
hydrogen
alkyl
methyl
hydrogen atom
Prior art date
Application number
NO812355A
Other languages
English (en)
Other versions
NO158578B (no
NO812355L (no
Inventor
Anton Mentrup
Kurt Schromm
Ernst-Otto Renth
Wolfgang Hoefke
Wolfram Gaida
Ilse Streller
Armin Fuegner
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NO812355L publication Critical patent/NO812355L/no
Publication of NO158578B publication Critical patent/NO158578B/no
Publication of NO158578C publication Critical patent/NO158578C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO812355A 1980-07-12 1981-07-10 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater. NO158578C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803026534 DE3026534A1 (de) 1980-07-12 1980-07-12 3,1-benzoxazin-2-one, ihre herstellung und verwendung

Publications (3)

Publication Number Publication Date
NO812355L NO812355L (no) 1982-01-13
NO158578B NO158578B (no) 1988-06-27
NO158578C true NO158578C (no) 1988-10-05

Family

ID=6107085

Family Applications (1)

Application Number Title Priority Date Filing Date
NO812355A NO158578C (no) 1980-07-12 1981-07-10 Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater.

Country Status (25)

Country Link
US (1) US4341778A (no)
EP (1) EP0043940B1 (no)
JP (1) JPS5748975A (no)
KR (1) KR850000755B1 (no)
AT (1) ATE9336T1 (no)
AU (1) AU540916B2 (no)
CA (1) CA1165317A (no)
DD (1) DD202018A5 (no)
DE (2) DE3026534A1 (no)
DK (1) DK149851C (no)
ES (4) ES503837A0 (no)
FI (1) FI74703C (no)
GB (1) GB2080296B (no)
GR (1) GR74333B (no)
HK (1) HK98286A (no)
HU (1) HU183515B (no)
IE (1) IE52508B1 (no)
IL (1) IL63285A (no)
NO (1) NO158578C (no)
NZ (1) NZ197678A (no)
PH (1) PH17425A (no)
PT (1) PT73338B (no)
SG (1) SG77686G (no)
YU (1) YU170181A (no)
ZA (1) ZA814687B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446319A (en) * 1981-04-28 1984-05-01 Takeda Chemical Industries, Ltd. Aminocyclitols and their production
JPS62238288A (ja) * 1986-04-04 1987-10-19 Nippon Tokushu Noyaku Seizo Kk 環状カルバメ−ト及び農園芸用殺菌剤
FR2636065B1 (fr) * 1988-09-08 1993-05-07 Fabre Sa Pierre Nouveaux derives de dihydro-2,3 arylacoylaminoalcoyl-3 4h-benzoxazine-1,3 ones-4, leur preparation et leur application en tant que medicaments utiles en therapeutique
JP2807577B2 (ja) * 1990-06-15 1998-10-08 エーザイ株式会社 環状アミド誘導体
FR2680172B1 (fr) * 1991-08-05 1993-11-19 Fabre Medicament Pierre Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
CA2210138A1 (en) * 1995-01-24 1996-08-01 Peter D. Williams Tocolytic oxytocin receptor antagonists
US5874430A (en) 1996-10-02 1999-02-23 Dupont Pharmaceuticals Company 4,4-disubstitued-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the same
DE102004003428A1 (de) 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
WO2006077821A1 (ja) * 2005-01-19 2006-07-27 Dainippon Sumitomo Pharma Co., Ltd. アルドステロン受容体調節剤としての芳香族スルホン化合物
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
UY30552A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Combinaciones farmacologiicas en base a derivados sustituidos de la n-(5-{2-[1,1-dimetil-propilamino]-1-hidroxi-metil}-2-hidroxi-fenil)-metansulfonamida y aplicaciones
WO2008023001A1 (en) * 2006-08-22 2008-02-28 Boehringer Ingelheim International Gmbh Powder formulations for inhalation containing enantiomerically pure beta-agonists
PE20080425A1 (es) * 2006-08-22 2008-06-16 Boehringer Ingelheim Int Formulacion aerosol para la inhalacion de beta-agonistas
UY30550A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526621A (en) * 1966-08-03 1970-09-01 Farmaceutical Italia Soc Substituted 3,1-benzoxazin-2-one
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US4163053A (en) * 1977-12-27 1979-07-31 Schering Corporation Anti-hypertensive 5-[2-(substituted anilinoalkylamino)-1-hydroxyalkyl]salicylamides
FI791727A (fi) * 1978-06-05 1979-12-06 Ciba Geigy Ag Foerfarande foer framstaellning av n-alkylerade aminoalkoholer
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen

Also Published As

Publication number Publication date
GB2080296B (en) 1983-09-28
KR850000755B1 (en) 1985-05-25
ATE9336T1 (de) 1984-09-15
PT73338B (en) 1983-06-20
DK149851B (da) 1986-10-13
ES8300725A1 (es) 1982-11-01
NZ197678A (en) 1984-12-14
DK306781A (da) 1982-01-13
EP0043940A1 (de) 1982-01-20
ES8205402A1 (es) 1982-06-01
YU170181A (en) 1983-10-31
IE52508B1 (en) 1987-11-25
DK149851C (da) 1987-05-04
ES508653A0 (es) 1982-11-01
IE811567L (en) 1982-01-12
ES503837A0 (es) 1982-06-01
KR830006248A (ko) 1983-09-20
FI74703C (fi) 1988-03-10
NO158578B (no) 1988-06-27
HK98286A (en) 1986-12-24
DD202018A5 (de) 1983-08-24
PH17425A (en) 1984-08-08
GB2080296A (en) 1982-02-03
FI812183L (fi) 1982-01-13
AU7273181A (en) 1982-09-16
JPS5748975A (en) 1982-03-20
NO812355L (no) 1982-01-13
ES8300726A1 (es) 1982-11-01
IL63285A (en) 1985-03-31
AU540916B2 (en) 1984-12-06
CA1165317A (en) 1984-04-10
ES508654A0 (es) 1982-11-01
EP0043940B1 (de) 1984-09-12
PT73338A (de) 1981-08-01
DE3026534A1 (de) 1982-03-18
US4341778A (en) 1982-07-27
DE3166003D1 (en) 1984-10-18
FI74703B (fi) 1987-11-30
IL63285A0 (en) 1981-10-30
SG77686G (en) 1987-02-27
GR74333B (no) 1984-06-25
ZA814687B (en) 1983-03-30
HU183515B (en) 1984-05-28
ES508655A0 (es) 1982-11-01
ES8300727A1 (es) 1982-11-01

Similar Documents

Publication Publication Date Title
NO158578C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater.
HUP9802694A1 (hu) Benzamidszármazékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
ES482134A1 (es) Un procedimiento para preparar derivados de 1-(3-mercapto- 2-metilpropanoil)-prolil-aminoacido.
HUP9701596A2 (hu) 2,4-Diamino-1,3,5-triazin-származékok, eljárás előállításukra, alkalmazásuk gyógyszerkészítmények előállítására és az ezeket tartalmazó gyógyszerkészítmények
DK118083D0 (da) Theophyllinylalkyloxadiazoler eller additionssalte deraf, deres fremstilling og anvendelse som laegemidler
IL64647A (en) 2,8-disubstituted-4-thiomorpholino-pyrimido(5,4-d)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
ATE119910T1 (de) Amphotericin b derivate.
ATE42295T1 (de) Penem-derivate, verfahren zu deren herstellung, ihre verwendung und pharmazeutische zusammensetzungen.
ES464013A1 (es) Procedimiento para preparar derivados sustituidos de orto- fenilendiamina.
ZA918991B (en) Imidazole compounds,process for the preparation thereof and pharmaceutical compositions containing them
PT83786A (de) Neue basisch substituierte pyridinverbindungen verfahren zu ihrer herstellung die sie enthaltenden arzneimittel und ihre verwendung
GR3000488T3 (en) Novel 1,4-dihydropyridines containing fluorine, process for their preparation and their use as medicaments
DE3166645D1 (en) Dibenzoxazonine, dibenzoxazecine, dibenzoxaazacycloundecane derivatives and their corresponding thia- and aza derivatives, their preparation and pharmaceutical compositions